Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Cash from Investing Activities (2016 - 2021)

Phio Pharmaceuticals' Cash from Investing Activities history spans 10 years, with the latest figure at -$30000.0 for Q3 2021.

  • For Q3 2021, Cash from Investing Activities fell 275.0% year-over-year to -$30000.0; the TTM value through Dec 2021 reached -$51000.0, down 168.42%, while the annual FY2025 figure was -$12000.0, 250.0% down from the prior year.
  • Cash from Investing Activities reached -$30000.0 in Q3 2021 per PHIO's latest filing, down from -$15000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $98000.0 in Q1 2017 to a low of -$186000.0 in Q2 2017.
  • Average Cash from Investing Activities over 5 years is -$17857.1, with a median of -$9000.0 recorded in 2020.
  • Peak YoY movement for Cash from Investing Activities: soared 200.0% in 2019, then plummeted 900.0% in 2020.
  • A 5-year view of Cash from Investing Activities shows it stood at -$15000.0 in 2017, then surged by 66.67% to -$5000.0 in 2018, then skyrocketed by 200.0% to $5000.0 in 2019, then tumbled by 120.0% to -$1000.0 in 2020, then tumbled by 2900.0% to -$30000.0 in 2021.
  • Per Business Quant, the three most recent readings for PHIO's Cash from Investing Activities are -$30000.0 (Q3 2021), -$15000.0 (Q2 2021), and -$6000.0 (Q1 2021).